Authors


Srini Dagalur

Latest:

CTMS: What You Should Know

The dilemma facing clinical operations executives when selecting a CTMS solution to manage clinical trials is to go with an existing approach/solution or explore alternative options.


Michael Herschel, MD

Latest:

SOPs in Clinical Research

Survey appraises the use of SOPs in clinical research from the sponsors' point of view.


Stephen Young

Latest:

Re-Branding "Risk-Based Monitoring" - A Call for "Targeted Site Quality Management"

With all of the buzz and excitement around risk-based monitoring, one might expect that the broad adoption of this emerging clinical research paradigm is well under way.


Dario Carrara

Latest:

Three-Pronged Approach to Optimizing Trial Monitoring

Study results using a quality-by-design method, risk-based monitoring, and real-time direct data entry.


Alison R. Manley

Latest:

Enhancing Trial Enrollment Through 'Goal Programming'

How iterative analysis of subject recruitment data can optimize outcomes during ongoing enrollment.


Rick Morrison

Latest:

Technology’s Role in Clinical Trials

How the use of eSource, eTMF, and other cloud-based solutions are changing clinical trials


Tomas Novak

Latest:

Decline of Trials in CEE: Fluctuation or Trend?

Examining why newly registered trials have fallen in Central and Eastern Europe, relative to other regions.


R. Jennifer Cavalieri

Latest:

Recruiting Strategies for Clinical Trials

Six years ago, our department of a large academic research center was having difficulty enrolling enough subjects in osteoporosis studies. We wanted to expand into a variety of trials and increase the number of participants. Despite our experience and expertise, our enrollments were down. We wondered if the pool of eligible participants was shrinking, if our competition was doing a better job than we were, or if we needed to modify our project management style.



Chris Watson

Latest:

Perspectives and Guidance for Effective eCOA in Global DCTs

Guidance on the unique challenges presented by electronic outcomes.


Lisa Haddican

Latest:

Three Reasons to Integrate a CTMS and EMR

Integrating a CTMS and an EMR can provide many benefits for supporting the health care needs of patients.


Daniel B. Goodman, MD

Latest:

Blood Pressure Evaluation During Early Phase Trials

A systematic approach for early identification of BP effects during development of new drugs.



Maria C. Harrison

Latest:

RBM in Late Phase

The reality of risk-based monitoring: history and successful implementation for late phase research.


Sarah Lampson

Latest:

Developing a Successful Peer-to-Peer Mentoring Program

Clinical research organizations should look to peer-to-peer mentoring for professional development.



Maxim Belotserkovsky

Latest:

Decline of Clinical Trials in Central and Eastern Europe: Fluctuation or Trend?

In some countries, the participation in clinical trial, is still the only possibility to be treated.


Karen Arts

Latest:

Developing a Successful Peer-to-Peer Mentoring Program

Clinical research organizations should look to peer-to-peer mentoring for professional development.


Robert Kleiman, MD

Latest:

The Benefits of Advanced Imaging Management Systems

How new technology can impact cardiac imaging in oncology clinical trials and have broader implications for patient safety.


Kathleen A. Mandziuk

Latest:

RBM in Late Phase

The reality of risk-based monitoring: history and successful implementation for late phase research.


Helen West

Latest:

Collaboration Planning

Sponsor-driven, CRO/recruitment provider collaborations propel cost-efficient study completion.


Neil Hawkins

Latest:

Health Technology Assessment in Clinical Development: When to Bridge Research and Decision-Making

Health technology assessment is a field of analysis that evaluates the medical, social, ethical, and economic implications of development, diffusion, and use of health technology.



Sergio Dalla Nora

Latest:

Three-Pronged Approach to Optimizing Trial Monitoring

Study results using a quality-by-design method, risk-based monitoring, and real-time direct data entry.


Fran Ross

Latest:

TMF Reference Model Standard = Process Efficiency

One of the many activities across the clinical development cycle that is non-negotiable is the creation, collection, management, and storage of the documents that are contained in the Trial Master File.


Ashish Goel

Latest:

Driving Successful Clinical Trial Supply Management through Global Data Collaboration

An effective clinical trial is one of the most crucial stages in the creation of a new drug.



Philip E. Doren

Latest:

Impact on the Future

The use of RBM may be the only way forward as long as the development of medicines relies on clinical testing.


Ivana Furimsky

Latest:

Developing a Successful Peer-to-Peer Mentoring Program

Clinical research organizations should look to peer-to-peer mentoring for professional development.


Michael R. Hamrell

Latest:

Three-Pronged Approach to Optimizing Trial Monitoring

Study results using a quality-by-design method, risk-based monitoring, and real-time direct data entry.

© 2024 MJH Life Sciences

All rights reserved.